Gene · 2160
Papers2,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Drug-Drug Interactions of FXI Inhibitors: Clinical Relevance. | Hematol Rep | 2024 | 38534886 | PubTator, text mining | PubMed |
| Incidental and secondary findings in trio exome sequencing. | Genes Dis | 2024 | 38523675 | PubTator, text mining | PubMed |
| The role of coagulation factors VIII, IX and XI in the prediction and mediation of recurrent thrombotic events in children with non-central venous catheter deep vein thrombosis. | Thromb Res | 2024 | 38484629 | PubTator, text mining | PubMed |
| Elevated factor XI is associated with recurrent left ventricular thrombus of unknown origin. | Eur J Clin Invest | 2024 | 38465770 | PubTator, text mining | PubMed |
| Systemic proteome adaptions to 7-day complete caloric restriction in humans. | Nat Metab | 2024 | 38429390 | PubTator, text mining | PubMed |
| Association between venous thromboembolism-associated genetic variants, coagulation factor levels, and thrombin generation potential. | EJHaem | 2024 | 38406509 | PubTator, text mining | PubMed |
| Levels of procoagulant factors and peak thrombin generation in relation to dementia risk in older adults: The Cardiovascular Health Study. | Thromb Res | 2024 | 38340522 | PubTator, text mining | PubMed |
| Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow. | J Thromb Haemost | 2024 | 38331196 | PubTator, text mining | PubMed |
| One case of surgical treatment of coagulation factor XI deficiency complicated with esophageal cancer: a case report. | J Cardiothorac Surg | 2024 | 38303013 | PubTator, text mining | PubMed |
| Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeks. | Res Pract Thromb Haemost | 2024 | 38282901 | PubTator, text mining | PubMed |
| Understanding the role of red blood cells in venous thromboembolism: A comprehensive review. | Am J Med Sci | 2024 | 38278361 | PubTator, text mining | PubMed |
| Mendelian Randomization Applied to Neurology: Promises and Challenges | Neurology | 2024 | 38261980 | PubTator, text mining | PubMed |
| Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy. | Int J Mol Sci | 2024 | 38256250 | PubTator, text mining | PubMed |
| CA125-Associated Activated Partial Thromboplastin Time and Thrombin Time Decrease in Patients with Adenomyosis. | J Multidiscip Healthc | 2024 | 38250313 | PubTator, text mining | PubMed |
| Construction and comparison of short-term prognosis prediction model based on machine learning in acute ischemic stroke. | Heliyon | 2024 | 38234895 | PubTator, text mining | PubMed |
| Activation of coagulation FXI promotes endothelial inflammation and amplifies platelet activation in a nonhuman primate model of hyperlipidemia. | Res Pract Thromb Haemost | 2024 | 38226339 | PubTator, text mining | PubMed |
| Pharmacological and clinical appraisal of factor XI inhibitor drugs. | Eur Heart J Cardiovasc Pharmacother | 2024 | 38196141 | PubTator, text mining | PubMed |
| Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients. | Acta Neuropathol Commun | 2024 | 38191511 | PubTator, text mining | PubMed |
| A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene. | Thromb J | 2024 | 38169400 | PubTator, text mining | PubMed |
| Proteomic profiling identifies SPP1 associated with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis. | Arthritis Res Ther | 2024 | 38167532 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2160/papers?page=13